| Title |
Treating COVID-19—Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics
|
|---|---|
| Published in |
JAMA: Journal of the American Medical Association, May 2020
|
| DOI | 10.1001/jama.2020.4742 |
| Pubmed ID | |
| Authors |
Andre C. Kalil |
X Demographics
The data shown below were collected from the profiles of 2,087 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 381 | 18% |
| Japan | 176 | 8% |
| Spain | 84 | 4% |
| United Kingdom | 74 | 4% |
| France | 60 | 3% |
| Canada | 52 | 2% |
| Brazil | 43 | 2% |
| Mexico | 35 | 2% |
| Italy | 25 | 1% |
| Other | 265 | 13% |
| Unknown | 892 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1510 | 72% |
| Scientists | 298 | 14% |
| Practitioners (doctors, other healthcare professionals) | 231 | 11% |
| Science communicators (journalists, bloggers, editors) | 48 | 2% |
Mendeley readers
The data shown below were compiled from readership statistics for 633 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 633 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 99 | 16% |
| Student > Bachelor | 60 | 9% |
| Student > Master | 58 | 9% |
| Other | 54 | 9% |
| Student > Ph. D. Student | 52 | 8% |
| Other | 142 | 22% |
| Unknown | 168 | 27% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 198 | 31% |
| Pharmacology, Toxicology and Pharmaceutical Science | 36 | 6% |
| Nursing and Health Professions | 26 | 4% |
| Biochemistry, Genetics and Molecular Biology | 25 | 4% |
| Agricultural and Biological Sciences | 19 | 3% |
| Other | 119 | 19% |
| Unknown | 210 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1833. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 April 2024.
All research outputs
#5,518
of 25,784,004 outputs
Outputs from JAMA: Journal of the American Medical Association
#167
of 36,821 outputs
Outputs of similar age
#358
of 425,344 outputs
Outputs of similar age from JAMA: Journal of the American Medical Association
#20
of 435 outputs
Altmetric has tracked 25,784,004 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 36,821 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 72.8. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 435 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.